Novavax, Inc. (NASDAQ: NVAX) is -7.92% lower on its value in year-to-date trading and has touched a low of $3.53 and a high of $11.36 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVAX stock was last observed hovering at around $4.43 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $4.42, the stock is -8.11% and -4.99% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.63 million and changing -0.23% at the moment leaves the stock -29.23% off its SMA200. NVAX registered -47.75% loss for a year compared to 6-month loss of -41.99%. The firm has a 50-day simple moving average (SMA 50) of $0.51 and a 200-day simple moving average (SMA200) of -$0.58.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -18.90% gain in the last 1 month and extending the period to 3 months gives it a -14.17%, and is -2.43% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.04% over the week and 5.76% over the month.
Novavax, Inc. (NVAX) has around 1543 employees, a market worth around $618.58M and $983.71M in sales. Fwd P/E is 35.84. Profit margin for the company is -55.41%. Distance from 52-week low is 25.13% and -61.09% from its 52-week high.
Novavax, Inc. quarterly earnings per share for the current quarter are estimated at -$0.95 with sales reaching $101.45M over the same period.The EPS is expected to grow by 85.27% this year, but quarterly earnings will post -13.60% year-over-year. Quarterly sales are estimated to grow 25.30% in year-over-year returns.
Novavax, Inc. (NVAX) Top Institutional Holders
278 institutions hold shares in Novavax, Inc. (NVAX), with institutional investors hold 59.28% of the company’s shares. The shares outstanding are 139.51M, and float is at 131.81M with Short Float at 36.51%. Institutions hold 56.32% of the Float.
The top institutional shareholder in the company is State Street Corporation with over 11.68 million shares valued at $86.78 million. The investor’s holdings represent 12.37% of the NVAX Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 10.57 million shares valued at $78.55 million to account for 11.20% of the shares outstanding. The other top investors are Blackrock Inc. which holds 6.99 million shares representing 7.41% and valued at over $51.97 million, while Shah Capital Management holds 6.71% of the shares totaling 6.33 million with a market value of $45.83 million.
